Biomedical Engineering Reference
In-Depth Information
k
1
s
C
A
0
ð1 þ k
1
s
Þð1 þ k
2
s
Þ
C
B
¼
(E5-8.14)
This maximum concentration of B (or the production rate of B) can be obtained by setting
s
m
¼
ð
1
þ
k
1
s
m
Þð
1
þ
k
2
s
m
Þ
s
m
½
k
1
ð
1
þ
k
2
s
m
Þþ
k
1
ð
1
þ
k
2
s
m
Þ
d
C
B
d
0 ¼
k
1
C
A
0
(E5-8.15)
2
2
s
ð1 þ k
1
s
m
Þ
ð1 þ k
2
s
m
Þ
which gives the contact time required for maximum production of B in a CSTR
1
k
2
k
1
s
m
¼
p
(E5-8.16)
and the corresponding concentration of B is given by
(E5-8.17)
s
!
2
k
2
k
1
C
B
max
¼ C
A
0
1 þ
Figure E5-8.3
shows the ratio of the maximum concentration B in a PFR,
Eqn (E5-8.10)
to that
in a CSTR,
Eqn (E5-8.17)
, as a function of the kinetic rate constant
k
2
/
k
1
. One can observe that the
productivity to B is higher in a PFR than in a CSTR, as the ratio is always greater than unity.
Therefore, the optimum reactor type is PFR, with a contact time given by
Eqn (E5-8.9)
if the
desired product is the intermediate product B.
Example 5-8 shows that PFR is better suited for intermediate product production. This can be
easily interpreted from the concentration distributions. In a CSTR, the reactant concentration is
1.5
1.4
1.3
1.2
1.1
1.0
10
-4
10
-3
10
-2
10
-1
10
0
10
1
10
2
10
3
10
4
k/k
2
1
FIGURE E5-8.3
The ratio of the maximum intermediate product B in a PFR to that in a CSTR as a function of the
kinetic rate constant ratio.
Search WWH ::
Custom Search